Chapter Activities

"Economic Evaluation of Vaccines: Opportunities and Challenges"

Two industry experts will provide an overview of approaches to evaluating the economic value of vaccines, followed by a moderated Q&A session:

  • Sara Poston, PharmD, Head, US Health Outcomes and Epidemiology, Vaccines, North American Medical Affairs, GSK
  • Craig Roberts, PharmD, VP, Vaccines, Center for Observational and Real-World Evidence, Merck
Date/Time: Thursday, June 17, 2021, 12-1pm ET
 
Zoom Meeting Link: https://lnkd.in/dGg2GU8
Passcode: 105344
Or One tap mobile :
    US: +12063379723,,99842292097#,,,,*105344#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
        US: +1 206 337 9723
        Canada: +1 204 272 7920
        Belgium: +32 1579 5132
        United Kingdom: +44 131 460 1196
        France: +33 1 7037 2246
Webinar ID: 998 4229 2097
Passcode: 105344
International numbers available: https://lnkd.in/dnFFK7t

Equal value of life-years gained alongside quality-adjusted life-years gained: ICER Analytics case studies
March 19, 2021

Speaker: Jon Campbell, PhD, Senior Vice President for Health Economics, Institute for Clinical and Economic Review (ICER)

Date/Time: Friday, March 19, 2021 | 12pm-1pm EST

The webinar will provide a brief overview of ICER and ICER updates. The speaker will also share recent learnings/experiences on evLYG and QALY using case studies from ICER Analytics.

Chapter Announces Board Election

We are very pleased to announce the results of the recent board election for the ISPOR Boston Chapter:

President-Elect
Noam Kirson, PhD, Managing Principal, Analysis Group

Director
Nick Li, PhD, MBA, Senior Director, HEOR, uniQure

Please join us in congratulating Noam and Nick!

Additional communication will come out soon regarding the ISPOR Boston Chapter events planned for 2021.

Meanwhile, please join the “ISPOR-Boston Regional Chapter” LinkedIn Group to stay connected. If you are a member of ISPOR and wish to become a member of the Boston chapter, please complete the registration form

Experiences and Insights from Women Leaders in HEOR
October 26, 2020

Please join us on Monday, October 26, 12 noon – 1 pm ET, for a panel discussion with Women in HEOR hosted by the ISPOR Boston Chapter!  This Webinar will feature a panel of HEOR women leaders from academia, consulting, and pharma/biotech, including:

Susan Garfield, DrPH: Susan runs Ernst & Young’s Health Sciences and Wellness commercial practice, helping clients bring innovations to the market.  As a health and behavioral economist, she has worked to help organizations understand how incentives flow through systems to drive organizational and systems-level change as well as the adoption of new technologies.  She is currently leveraging her Public Health background to focus on many COVID-related related challenges including deploying testing at scale, building greater resilience for companies related to health risks, and COVID-19 vaccine enablement.

Kathleen Gondek, PhD: Kathleen is the Vice President of Global Evidence and Outcomes at Takeda. She has 30+ years of experience in outcomes research spanning multiple disease areas and providing evidence from early development through commercialization.

Paige Lin, PhD: Paige is an Associate Professor of Medicine at the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center.  She is an HEOR researcher specializing in analyzing the value of health care interventions and assessing quality of care, patient outcomes, and economic impact on vulnerable populations, such as persons with Alzheimer’s disease.

Amy O'Sullivan, PhD: Amy is Vice President of Health Economics and Outcomes Research (HEOR) at Alkermes, Inc. She is a health economist with over 20 years of experience conducting economic and outcomes research of medical interventions in consulting and industry environments.

Moderator: Josephine Li-McLeod, RPh, PhD: Josephine is Chief Strategy Officer at Stratevi, LLC. She has spent 20+ years in HEOR leading teams, developing people, shaping product strategy and generating evidence to optimize patient access to therapies.

ISPOR Boston Summer Event Is Going Virtual!

Title: Patient Experience Data: An Introduction to Strategic, Labeling, and Methodologic Considerations

Speakers: Dana DiBenedetti, PhD, Executive Director, Patient-Centered Outcomes Assessment & Ari Gnanasakthy, MBA, MSc, Principal Scientist, RTI Health Solutions. 

 The webinar will provide a brief overview of patient experience data (PED), PED collection, its' value, and how it's being used by the FDA. Speakers will also share recent learnings/experiences in PED based on interactions with the FDA, and provide insight on future directions.

Date/Time: Monday, June 29, 2020 | 3pm-4pm EDT

Webinar Title: New Pricing Policies for New Cures: Thinking about Pricing and Access in the Context of COVID-19  

Speaker: Rena Conti, PhD, Associate Professor, Markets, Public Policy and Law;  Associate Research Director, Institute for Health Systems Innovation and Policy. Boston University, Questrom School of Business 

Date: Monday, May 11, 2020

Time: 1.00PM - 2.00PM EDT 

“New Pricing Policies for New Cures: What Can We Learn From Louisiana?”

New medicines promise cure from dreadful disease, but come with increasingly hefty price tags. Patients and payers – particularly those with fixed annual budgets - are left scrambling to decide whether and who will receive treatment. The session will try to answer the question, whether new cures require new pricing policies. First, we will discuss the rationale, design, and implementation of one of the most important and innovative models to ensure access to cure currently implemented in the US - the State of Louisiana’s Hepatitis C subscription model. Second, we will comment on the widespread implications of this model and other pricing alternative initiatives with great promise to improve health, wealth, and equity.

Speaker: Rena Conti, PhD, Associate Professor, Markets, Public Policy, and Law; Associate Research Director, Institute for Health System Innovation and Policy, Boston University Questrom School of Business

Date/Time: Tuesday, March 17, 2020, 6:00PM – 8:30PM

Location: 35 Landsdowne Auditorium; Takeda Pharmaceuticals, 35 Landsdowne, Cambridge, MA 02139

Light appetizers and refreshments will be provided. Preregistration is required for this event. Please complete this online form by Thursday, March 12, 2020.

Join our LinkedIn Group ISPOR-Boston Regional Chapter to stay connected.


Chapter Announces Board Election


We are very pleased to announce the results of the recent board election for the ISPOR Boston Chapter:

President-Elect

Amy O’Sullivan, Vice President, Health Economics and Outcomes Research, Alkermes Inc

Please join us in welcoming Amy to the ISPOR Boston Chapter board!  

Additional communication will be coming out soon with regards to our first ISPOR Boston Chapter event for the year currently planned for March 2020.

 Thank you to all who participated in the nomination process!

- The Executive Committee -


 

October 22, 2019

“Unambiguous Reporting and Replicability of ‘Real-World’ Evidence from ‘Real-World’ Data” 

Featured Speaker: Speaker: Shirley Wang, PhD, ScM, Brigham & Women’s Hospital, Harvard Medical School, Division of Pharmacoepidemiology & Pharmacoeconomics

Date and Time: Tuesday, October 22, 2019, 6:00PM – 8:30PM (check in/networking at 6:00PM; ISPOR Boston Chapter updates at  6:45PM; seminar at 7:00PM)

Location: EY Boston Office; 200 Clarendon Street, 23rd Floor; Boston, MA 02116

Transportation: Closest T stop is Back Bay Station (Orange Line). Nearby Parking Garages: 100 Clarendon Street, Boston, MA 02116

Light appetizers and refreshments will be provided.

Please complete this online form by Friday, October 18. The RSVP is to allow for building registration and badging. Please note, no confirmation email will be sent.

 

“Career Journeys: Perspectives by Practice Setting”

ISPOR Boston’s Fall event was held September 18, 2019

Are you a Boston ISPOR member who has ever wondered what it would be like to work in a completely different practice setting? Or are you a student or new professional wanting to learn more about practice setting options and opportunities? Tthe ISPOR Boston Chapter Fall event was held on September 18, 2019. ISPOR Boston Chapter members from academia, manufacturering, payer/HTA/nontraditional, consulting, and non-HEOR or market access practice setting spoke. Each practice setting discussion was led by roundtable leaders who shared their own career journeys that led them to their current practice setting. Participants had the opportunity to participate in 3 roundtables throughout the evening.  This event was a great opportunity to reflect on career interests and meet fellow ISPOR members from the greater Boston areal

Join the “ISPOR-Boston Regional Chapter” LinkedIn Group to stay connected.

Please feel free to share this information with other Boston-based HEOR practitioners who may be interested in joining the event. To become a member of the chapter, please complete the online form.


“Economic Dimensions of Disruptive Innovations That Change the Practice of Medicine”

ISPOR Boston Chapter Spring event was held on May 2, 2019.

Featured Speaker: Ernst Berndt, Professor of Applied Economics at MIT

To become a member of the chapter, please complete the online form.

 

"The Death of Statistical Significance Testing"

Date and Time: Tuesday, December 4, 2018; 6:00PM - 9:00PM

Location: Analysis Group, 111 Huntington Ave, 13th Floor, Boston, MA 02199

Featured Speaker: Kenneth Rothman, Professor, Boston University

Discussant: James Signorovitch, Managing Principal, Analysis Group

“Null hypothesis significance testing is not yet dead, but from this talk you will learn why it ought to be.  Although seemingly quantitative, significance testing amounts to degrading quantitative information into a dichotomy, based on the P-value.  This process is conducive to egregious misinterpretations of data, stemming from the mixing of two essential data descriptors, strength of relation and precision, into a single number or label.  The American Statistical Association has issued a warning against significance testing, part of a growing drumbeat to ditch this flawed method and replace it with a more insightful and reliable approach to data analysis.”

 


Boston Regional Chapter - Event Archive:

2nd Panel on Cost-Effectiveness in Health and Medicine: Key issues and a worked example

Date and Time: Wednesday, November 1, 2017, 6:00-8:00PM (refreshments/networking at 6:00PM; seminar at 6:30PM)
Location: Shire, 650 E Kendall St, Cambridge MA 02144

Featured Speaker: 
Peter J. Neumann, Professor, Tufts University School of Medicine; Director, Center for the Evaluation of Value and Risk in Health, Tufts Medical Center

Discussants:

David D. Kim, PhD, MS, Assistant Professor, Tufts University School of Medicine; Center for the Evaluation of Value and Risk in Health, Tufts Medical Center

Issa J. Dahabreh, MD, MS, Assistant Professor, Brown University School of Public Health; Associate Director, Center for Evidence Synthesis in Health 

Light refreshments will be provided.

Please RSVP by Tuesday, October 24 using the form below. The RSVP is to allow for building registration and badging. Since space is limited, please email isporboston@gmail.com with cancellations to ensure that everyone who would like to attend can.

Check out our activities at https://www.ispor.org/member-groups/global-groups/regional-chapters/boston-regional-chapter/

Join our LinkedIn Group to stay connected: https://www.linkedin.com/groups/13521598

Please feel free to forward this email along to other Boston-based HEOR practitioners who may be interested in joining the ISPOR Boston Regional Chapter. To become a member of the chapter, please complete the following form: https://goo.gl/forms/rL0bL0xjIXpXuP133


-- The Executive Committee –
Brian Rittenhouse, PhD (MCPHS University) Lisa Meckley, PhD (Shire)
Paige Lin, PhD (Tufts Medical Center) Matt Sussman, MA (Boston Health Economics)
Parashar Patel, MPA (Boston Scientific) Julie Locklear, MBA, PharmD (EMD Serono)

 


 

"Heterogeneity of Treatment Effect and Implications for Clinical Trial Design and Analysis"

Wednesday, June 21, 2017, 6:00-7:30PMIt was great to see many of you at the ISPOR 22nd Annual International Meeting in Boston! Now that our ISPOR Boston Regional Chapter is official, we would like to invite you to the inaugural event on June 21st.  This will be a great opportunity to network, meet members from the greater Boston area, and participate in a discussion of treatment heterogeneity in clinical trials. RSVP here: https://goo.gl/forms/gWbCKTAlq1LVCWZF3Date and Time: Wednesday, June 21st, 6:00-7:30PM (refreshments/networking at 6:00PM; seminar at 6:30PM) Location: Tufts Dental School, 1 Kneeland Street, Room 1414, Boston, MA 02111 Speaker: David Kent, MD, MS, Professor, Tufts University School of Medicine; Director, Predictive Analytics and Comparative Effectiveness (PACE) Center, Tufts Medical Center Light refreshments will be provided.Seating is limited; please only RSVP if you plan to attend.  We will close registration when we reach capacity.Check out our activities at: https://www.ispor.org/member-groups/global-groups/regional-chapters/boston-regional-chapter/Join our LinkedIn Group to stay connected.Please feel free to forward this email along to other Boston-based HEOR practitioners who may be interested in joining the ISPOR Boston Regional Chapter.

 


 

ISPOR's Annual International Meeting In Boston

 
  • Learn about different and innovative applications in the conduct and use of HEOR.
  • Engage with recognized global experts in the field.
  • Network with colleagues, collaborators, and clients
  • Share your research and ideas with other ISPOR members in an open and objective environment.
  • Stay current on emerging trends in health care
  • Advance your career by being and active participant in ISPOR events (i.e., attend an ISPOR Short Course program or In-Person Training, present a poster, network with world-renowned leaders in HEOR).

First Plenary Session:

Where is U.S. Health Policy Going?

Monday, May 22, 2017 – 8:30 AM - 10:30 AM

 

Second Plenary Session:

Social Network Interventions and Population Health

Tuesday, May 23, 2017 – 8:30 AM - 10:30 AM 

 

Third Plenary Session:

When Do We Really Need Randomized Controlled Trials?

Wednesday, May 24, 2017 – 10:15 AM - 12:00 PM

 

For The Full Schedule Of Events: https://www.ispor.org/Event/Program/2017Boston

Access Released Presentations: https://www.ispor.org/Event/ReleasedPresentations/2017Boston 


 

"Aligning Drug/Device Prices and Benefits: A Novel Framework for Examining Questions of Comparative Effectiveness, Cost-Effectiveness, and Affordability"

Date: March 28, 2016

Speaker: Dan Ollendorf, PhD,Chief Scientific Officer, Institute for Clinical and Economic Review (ICER)

Discussants: 
Josh Cohen, PhD,  Deputy Director and Associate Professor, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center; 
Joe Menzin, PhD, President, Boston Health Economics

Sponsor/Location: The Analysis Group (111 Huntington Ave, Boston)

Attendance: Approximately 100

 


 

Adaptive Pathways - What's in it for Payers?

Date: September 24, 2015

Speaker: Mark Trusheim, MS (visiting scientist at MIT’s Sloan School of Management)

Discussants:
Keith Flaherty, MD (Director, Henri and Belinda Termeer Center for Targeted Therapies, MGH Cancer Center)
Mohan Bala, PhD, MBA (VP, Health Economics Outcomes Research, Sanofi)

Sponsor/Location: Biogen (Cambridge-Kendall Square):  225 Binney Street, Cambridge

Attendance: approximately 100

 


 

The Value of Specialty Drugs

Date and Time: Monday, April 27, 2015, 6:00-8:00PM

Speaker: James Chambers, PhD (Tufts Medical Center)

Discussants: 
Peter Neumann, ScD (Tufts Medical Center)
Chris Leibman, PharmD, MS, (VP, GMAx-HEOR, Biogen)

Sponsor/Location: Biogen (Cambridge-Kendall Square):  225 Binney Street, Cambridge 

Attendance: approximately 100

BostonChapterEvent-Sept24 

Contact Information

Boston Regional Chapter Office

Email

Chapter Leadership

President

Amy K. O'Sullivan, PhD

President-Elect

Noam Yair Kirson, PhD

Past PresidentAjibade O. Ashaye, MD, MBA, MPH, MSc

Secretary/Treasurer

Josephine Li-McLeod, RPh, PhD
DirectorNick Li, PhD, MBA
Director

Paige Lin, PhD

DirectorMatt Sussman, MA
DirectorEllison Dial Suthoff, MBA

 

Annual Reports

  • Annual Report 2018

 

Chapter President, Brian Rittenhouse introduces speaker at recent event

Networking during a recent Boston Chapter meeting

Panelists, Mohan Bala, M. Trusheim, Keith Flaherty

Panelists, Mohan Bala, M. Trusheim, Keith Flaherty

image472

Chapter President, Brian Rittenhouse introduces speaker at recent event

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×